Optimal doses of paclitaxel and carboplatin combination chemotherapy for ovarian cancer: a phase I modified continual reassessment method study

✍ Scribed by Tokai Gynecologic Oncology Group (Tokai GOG); K. Kuzuya; H. Ishikawa; T. Nakanishi; F. Kikkawa; A. Nawa; H. Fujimura; A. Iwase; Y. Arii; M. Kawai; S. Hattori; K. Sakakibara; E. Sasayama; Y. Furuhashi; T. Suzuki; S. Mizutani

• Publisher: Springer
• Year: 2001
• Tongue: English
• Weight: 55 KB
• Volume: 6
• Category: Article
• ISSN: 1341-9625
• DOI: 10.1007/s10147-001-8027-7